[Familial transmission of hepatitis C virus]. 1996

V Díaz Morant, and M de la Mata, and G Costán, and M Delgado, and E Fraga, and J L Montero, and J Montero, and G Miño
Servicio de Aparato Digestivo Hospital, Reina Sofía, Córdoba.

OBJECTIVE To establish the prevalence of antibodies to hepatitis C virus (HCV) among relatives and other persons cohabiting with HCV carriers, as an indication of the risk of intradomestic transmission. METHODS A transversal study of series of clinical cases. A questionnaire was applied to the index cases (IC) and contact cases (CC), differentiating sexual contacts (SC) from non sexual contacts (NSC). METHODS One hundred and sixty four IC and 533 CC were included. Information on parenteral risk factors, type of sexual relationship, period of exposure, and other epidemiological variables was obtained. Antibodies to HCV (HCV-Ab) were determined by 2nd generation ELISA. RESULTS In eighty eight IC (53.6%) no parenteral risk factors were found. In 99 IC (62.8%) a liver biopsy showed chronic hepatitis or cirrhosis. Twelve CC (2.25%) turned out to be HCV-Ab (+), a ratio above that found in our city (0.3%, p < 0.001), however the comparison should be taken with caution. No significant differences were found with respect to several epidemiological variables, including type of sexual relationship, and socioeconomic indicators, between CC HCV-Ab (+) and (-). Stage of liver disease in the IC and relationship between IC and CC did not increase the risk of being HCV-Ab positive. In HCVAb positive CC a higher proportion of parenteral risk factors (p < 0.001), elevated ALT (p < 0.001) and sharing of personal tools (p < 0.01) were observed. CONCLUSIONS Intrafamiliar transmission of HCV is poorly documented and it is related to the presence of parenteral risk factors. The actual prevalence of HCVAb in a general population is unknown, rendering difficult to make definite conclusions.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D003075 Coitus The sexual union of a male and a female, a term used for human only. Sexual Intercourse,Coital Frequency,First Intercourse,Coital Frequencies,First Intercourses,Frequencies, Coital,Frequency, Coital,Intercourse, First,Intercourse, Sexual,Intercourses, First
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005190 Family A social group consisting of parents or parent substitutes and children. Family Life Cycles,Family Members,Family Life Cycle,Family Research,Filiation,Kinship Networks,Relatives,Families,Family Member,Kinship Network,Life Cycle, Family,Life Cycles, Family,Network, Kinship,Networks, Kinship,Research, Family
D005260 Female Females
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

V Díaz Morant, and M de la Mata, and G Costán, and M Delgado, and E Fraga, and J L Montero, and J Montero, and G Miño
February 1995, Gastroenterologie clinique et biologique,
V Díaz Morant, and M de la Mata, and G Costán, and M Delgado, and E Fraga, and J L Montero, and J Montero, and G Miño
November 1998, Medicina clinica,
V Díaz Morant, and M de la Mata, and G Costán, and M Delgado, and E Fraga, and J L Montero, and J Montero, and G Miño
October 2003, Revista medica de Chile,
V Díaz Morant, and M de la Mata, and G Costán, and M Delgado, and E Fraga, and J L Montero, and J Montero, and G Miño
June 1976, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
V Díaz Morant, and M de la Mata, and G Costán, and M Delgado, and E Fraga, and J L Montero, and J Montero, and G Miño
May 1993, The European journal of medicine,
V Díaz Morant, and M de la Mata, and G Costán, and M Delgado, and E Fraga, and J L Montero, and J Montero, and G Miño
September 1990, Annals of internal medicine,
V Díaz Morant, and M de la Mata, and G Costán, and M Delgado, and E Fraga, and J L Montero, and J Montero, and G Miño
May 2001, The New England journal of medicine,
V Díaz Morant, and M de la Mata, and G Costán, and M Delgado, and E Fraga, and J L Montero, and J Montero, and G Miño
January 1999, Journal of hepatology,
V Díaz Morant, and M de la Mata, and G Costán, and M Delgado, and E Fraga, and J L Montero, and J Montero, and G Miño
January 1994, Journal of gastroenterology and hepatology,
V Díaz Morant, and M de la Mata, and G Costán, and M Delgado, and E Fraga, and J L Montero, and J Montero, and G Miño
January 1999, Journal of hepatology,
Copied contents to your clipboard!